Skip to main content

Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study

Zenith TX2® Post-market Approval Study

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Zenith TX2® Post-market Approval Study

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial

Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Treatments Against RA and Effect on FDG-PET/CT

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Treatments Against RA and Effect on FDG-PET/CT

Treatment of Strongyloides Infection

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Treatment of Strongyloides Infection

Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 123
  • Page 124
  • Page 125
  • Page 126
  • Page 127
  • Page 128
  • Page 129
  • Page 130
  • Page 131
  • …
  • Next page Next
  • Last page Last
Subscribe to